Literature DB >> 209211

Detection of proviral DNA in horse cells infected with equine infectious anemia virus.

N R Rice, S Simek, O A Ryder, L Coggins.   

Abstract

Equine infectious anemia virus (EIAV) recently has been shown to possess a high-molecular-weight RNA genome and a virion reverse transcriptase. We completed the demonstration that EIAV is a retrovirus by showing the presence of proviral DNA in equine cells infected in vitro, but not in normal horse DNA. These studies were performed by using a highly representative cDNA probe synthesized by the virion polymerase. It was found that this cDNA reassociated extensively, and with high thermal stability, with either viral RNA or DNA extracted from infected cells, but showed no detectable reassociation with DNA from uninfected horse cells. Similarly, sequences related to EIAV were neither found in the DNA of four other Equus species, nor in a variety of other mammals including sheep, cows, pigs- dogs, cats, and humans; nor did EIAV cDNA hybridize with a variety of other retrovirus RNAs. These experiments were performed under conditions of very low stringency to enable detection of distantly related sequences, with a sufficient ratio of DAN to cDNA to allow detection of less than one viral copy per haploid genome. We conclude that EIAV is not an endogenous virus of the horse or of the other species tested.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209211      PMCID: PMC525883     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  PREVENTIVE MEASURES IN CATTLE LEUKEMIA: LEUKOSIS ENZOOTICA BOVIS.

Authors:  H J BENDIXEN
Journal:  Ann N Y Acad Sci       Date:  1963-11-04       Impact factor: 5.691

2.  SEDIMENTATION STUDIES OF THE SIZE AND SHAPE OF DNA.

Authors:  F W STUDIER
Journal:  J Mol Biol       Date:  1965-02       Impact factor: 5.469

3.  Equine infectious anemia: a retrospective study of an epizootic.

Authors:  N W Umphenour; M J Kemen; L Coggins
Journal:  J Am Vet Med Assoc       Date:  1974-01-01       Impact factor: 1.936

4.  Multiple divergent copies of endogenous C-type virogenes in mammalian cells.

Authors:  R E Benveniste; G J Todaro
Journal:  Nature       Date:  1974-11-08       Impact factor: 49.962

5.  Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma.

Authors:  J M Miller; L D Miller; C Olson; K G Gillette
Journal:  J Natl Cancer Inst       Date:  1969-12       Impact factor: 13.506

6.  Method for reproducible large-volume production and purification of Rauscher murine leukemia virus.

Authors:  R W Johnson; A Perry; O R Robinson; G P Shibley
Journal:  Appl Environ Microbiol       Date:  1976-02       Impact factor: 4.792

7.  Distribution of Mason-Pfizer virus-specific sequences in the DNA of primates.

Authors:  W Drohan; D Colcher; G Schochetman; J Schlom
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

8.  Characterization of RNA from equine infectious anemia virus.

Authors:  W P Cheevers; B G Archer; T B Crawford
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

9.  Mason-Pfizer virus characterization: a similar virus in a human amniotic cell line.

Authors:  W P Parks; R V Gilden; A F Bykovsky; G G Miller; V M Zhdanov; V D Soloviev; E M Scolnick
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

10.  RNA-dependent DNA polymerase associated with equine infectious anemia virus.

Authors:  B G Archer; T B Crawford; T C McGuire; M E Frazier
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

View more
  13 in total

1.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Specificity of response to viral proteins in horses infected with equine infectious anemia virus.

Authors:  H Charman; C Long; L Coggins
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Synthesis of long complementary DNA in the endogenous reaction by equine infectious anemia virus.

Authors:  N R Rice; L Coggins
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

4.  Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus.

Authors:  R C Montelaro; N Lohrey; B Parekh; E W Blakeney; C J Issel
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.

Authors:  O Salinovich; S L Payne; R C Montelaro; K A Hussain; C J Issel; K L Schnorr
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

6.  Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections.

Authors:  S Rasty; B R Dhruva; R L Schiltz; D S Shih; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.

Authors:  P M Rwambo; C J Issel; W V Adams; K A Hussain; M Miller; R C Montelaro
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

8.  Characterization of the infection of equine fibroblasts by equine infectious anemia virus.

Authors:  P Klevjer-Anderson; W P Cheevers; T B Crawford
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

9.  Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.

Authors:  J M Casey; Y Kim; P R Andersen; K F Watson; J L Fox; S G Devare
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

10.  Analysis of the nucleic acid components in reticuloendotheliosis virus.

Authors:  S Simek; N R Rice
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.